Retrospective analysis of surgical complications following cadaveric kidney transplantation in the modern transplant era
Authors:
- Domingo HernándezDHDomingo Hernández
- Margarita RufinoMRMargarita Rufino
- Silvia ArmasSASilvia Armas
- Ana GonzálezAGAna González
- Pedro GutiérrezPGPedro Gutiérrez
- Pablo BarberoPBPablo Barbero
- Sofía VivancosSVSofía Vivancos
- Concepción RodríguezCRConcepción Rodríguez
- José Rodríguez de VeraJVJosé Rodríguez de Vera
- Armando TorresATArmando Torres
- 4 July 2006
- journal article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 21 (10) , 2908-2915
Abstract
Risk factors for surgical complications (SCs) following kidney transplantation in the modern transplant era need to be identified to perform appropriate prophylactic interventions. Records from 870 consecutive adult cadaveric kidney transplants done at a single centre were reviewed. SCs were classified into four groups: (i) vascular (12%, thrombosis or stenosis); (ii) haemorrhagic (12%); (iii) ureteral (7.5%, leaks and stenosis) and (iv) wound (16%, lymphocoeles or dehiscences). One or more SCs occurred in 299 (34%) patients, with multiple SCs in 65 (7.4%). By logistic regression analysis, recipient vessel atherosclerosis and delayed graft function (DGF) were significantly associated with both thrombotic complications [odds ratio (OR) 4, 95% confidence interval (CI), 1.4-11, P = 0.010 and OR 3.8, 1.3-12, P < 0.00001, respectively] and graft artery stenosis (OR 2.9, 1.2-6.8, P = 0.015 and OR 5.6, 2.3-13.4, P < 0.0001, respectively). Acute rejection increased the risk of graft artery or ureteral stenosis by 2.5 (CI 1.02-6.4, P = 0.045) and 3.3 (CI 1.1-10, P = 0.034), respectively. Older recipients were related to urinary leak (OR 1.04, CI 1.01-1.07, P = 0.011). Difficult bench surgery, DGF and the use of antiplatelet drugs increased the risk of bleeding by 3.6 (CI 1.9-6.4, P < 0.0001), 2.7 (CI 1.5-4.7, P < 0.0001) and 1.8 (CI 1.03-3.29, P = 0.038), respectively. Each month on dialysis increased the risk by 1.02 (CI 1.01-1.03, P = 0.002). Sirolimus increased the risk for wound SCs by 4.1 (CI 2.1-8.3, P < 0.0001) and obesity, retransplant and acute rejection were additional risk factors. Adult renal transplant recipients at risk for SCs can be identified by age, DGF, graft vessel and recipient atheromatosis, difficult bench surgery, obesity, rejection and the use of antiplatelet drugs and rapamycin.Keywords
This publication has 20 references indexed in Scilit:
- Surgical Complications After Kidney TransplantationSeminars in Dialysis, 2005
- Clinical impact of preexisting vascular calcifications on mortality after renal transplantationKidney International, 2005
- Single-Center Study of Technical Graft Loss in 714 Consecutive Renal TransplantsTransplantation, 2004
- The Influence of Various Maintenance Immunosuppressive Drugs on Lymphocele Formation and Treatment After Kidney TransplantationJournal of Urology, 2004
- The impact of sirolimus, mycophenolate mofetil, cyclosporine, azathioprine, and steroids on wound healing in 513 kidney-transplant recipientsTransplantation, 2003
- Comparison of Sirolimus vs. Mycophenolate Mofetil on Surgical Complications and Wound Healing in Adult Kidney TransplantationAmerican Journal of Transplantation, 2003
- Vascular Complications After Live Donor Renal Transplantation: Study of Risk Factors and Effects on Graft and Patient SurvivalJournal of Urology, 2003
- ARE WOUND COMPLICATIONS AFTER A KIDNEY TRANSPLANT MORE COMMON WITH MODERN IMMUNOSUPPRESSION?Transplantation, 2001
- Primary renal graft thrombosisNephrology Dialysis Transplantation, 1996
- Urological Complications in 1,000 Consecutive Renal Transplant RecipientsJournal of Urology, 1995